跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Budenofalk - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Budenofalk
Approved
STANDARD
Budenofalk
Losan Pharma GmbH
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
d3a1e9f7beadb75d
Company
Losan Pharma GmbH
Type
Standard
Approval Details
Approval Id
d3a1e9f7beadb75d
Drug Approval Philippines Name
Budenofalk
Product Name
Budenofalk
Registration Number
DR-XY27181
Brand Name
Budenofalk
Generic Name
Budesonide
Dosage Form
Enteric-Coated Pellets in Capsule
Dosage Strength
3 mg
Manufacturer
Losan Pharma GmbH
Trader
Dr. Falk Pharma GmbH
Importer
A. Menarini Philippines, Inc.
Distributor
A. Menarini Philippines, Inc.
Company Detail Path
/organization/losan-pharma-gmbh
Trader Detail Path
/organization/doktor-falk-farma-gmbkh-predstavitelstvo
Issuance Date
25 May 2025
Expiry Date
07 November 2031
Pharmacologic Category
Intestinal Anti-Inflammatory Agent
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
d3a1e9f7beadb75d
Type
Standard
Back to Philippines FDA Approvals